SELLAS Life Sciences Group, Inc.

Nasdaq:SLS

Pharmaceutical Preparations·NEW YORK, NY

Governanceproxy statements · beneficial ownership

Proxy Statements

40 shown

Filed	Form	Description
6/10/25	DEFA14A	DEFA14A	→
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
↓